Coloplast agrees to act on UK DTI's (Department of Trade and Industry's) request
This article was originally published in Clinica
Danish company Coloplast says it will comply with demands set out by the UK Department of Trade and Industry (DTI) relating to its acquisition of UK company SSL International's continence care business, because of anti-competition concerns. Coloplast agreed to pay $118m for the business in September 2001 (see Clinica No 978, p 9).
You may also be interested in...
Lannett will launch a further seven products in fiscal 2021, after launching four products recently in the first quarter of FY21. The company also plans to pay off its Term Loan ‘A’ in full, by the end of November 2020.
Pfizer has now received a formal European Commission approval for its Nyvepria biosimilar pegfilgrastim. The approval puts the firm in direct competition with several other versions of the Neulasta original.
AstraZeneca's research head admits that the half dose approach was a lucky mistake - but one that could boost the vaccine's effectiveness and supplies. The US regulator may not be persuaded, however.